Green Cross Holdings Corporation (005257.KS)
KRW 23150.0
(1.09%)
KRW 23150.0
(1.09%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -2333.42 KRW | -140.69% |
| 2022 | 5734.87 KRW | -46.87% |
| 2021 | 10.79 Thousand KRW | 53.42% |
| 2020 | 7036.33 KRW | 811.47% |
| 2019 | -988.98 KRW | -132.78% |
| 2018 | 3017.00 KRW | -35.33% |
| 2017 | 4665.00 KRW | -14.42% |
| 2016 | 5451.00 KRW | -33.63% |
| 2015 | 8213.00 KRW | 13.13% |
| 2014 | 7260.00 KRW | 18.24% |
| 2013 | 6140.00 KRW | 24.09% |
| 2012 | 4947.96 KRW | -4.31% |
| 2011 | 5170.87 KRW | -51.13% |
| 2010 | 10.58 Thousand KRW | 27.68% |
| 2009 | 8286.34 KRW | 63.28% |
| 2008 | 5075.05 KRW | 9.6% |
| 2007 | 4630.46 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -797.32 KRW | 64.05% |
| 2024 Q1 | -2217.83 KRW | -27.4% |
| 2024 Q3 | 2849.43 KRW | 457.38% |
| 2023 FY | - KRW | -140.69% |
| 2023 Q4 | -1740.87 KRW | -242.72% |
| 2023 Q3 | 1219.80 KRW | 419.44% |
| 2023 Q2 | 234.83 KRW | 112.11% |
| 2023 Q1 | -1938.57 KRW | -1070.63% |
| 2022 Q4 | -165.60 KRW | -105.04% |
| 2022 Q1 | 1580.17 KRW | -66.52% |
| 2022 Q2 | 1133.55 KRW | -28.26% |
| 2022 FY | - KRW | -46.87% |
| 2022 Q3 | 3286.15 KRW | 189.9% |
| 2021 Q3 | 4705.00 KRW | 1662.17% |
| 2021 Q4 | 4719.54 KRW | 0.31% |
| 2021 Q1 | 1293.00 KRW | 0.03% |
| 2021 FY | - KRW | 53.42% |
| 2021 Q2 | 267.00 KRW | -79.35% |
| 2020 Q3 | 5337.00 KRW | 528.62% |
| 2020 Q1 | -378.00 KRW | 81.08% |
| 2020 Q4 | 1292.65 KRW | -75.78% |
| 2020 FY | - KRW | 811.47% |
| 2020 Q2 | 849.00 KRW | 324.6% |
| 2019 FY | - KRW | -132.78% |
| 2019 Q4 | -1997.52 KRW | -197.73% |
| 2019 Q2 | -807.00 KRW | -285.09% |
| 2019 Q3 | 2044.00 KRW | 353.28% |
| 2019 Q1 | 436.00 KRW | 396.24% |
| 2018 Q3 | 1456.00 KRW | 337.24% |
| 2018 FY | - KRW | -35.33% |
| 2018 Q4 | -147.18 KRW | -110.11% |
| 2018 Q2 | 333.00 KRW | -75.78% |
| 2018 Q1 | 1375.00 KRW | 533.02% |
| 2017 FY | - KRW | -14.42% |
| 2017 Q4 | -317.54 KRW | -113.39% |
| 2017 Q3 | 2371.00 KRW | 7.33% |
| 2017 Q2 | 2209.00 KRW | 448.14% |
| 2017 Q1 | 403.00 KRW | -75.77% |
| 2016 FY | - KRW | -33.63% |
| 2016 Q3 | 1937.00 KRW | 39.25% |
| 2016 Q4 | 1663.00 KRW | -14.15% |
| 2016 Q2 | 1391.00 KRW | 205.71% |
| 2016 Q1 | 455.00 KRW | 273.47% |
| 2015 FY | - KRW | 13.13% |
| 2015 Q4 | -262.30 KRW | -105.29% |
| 2015 Q1 | 1074.00 KRW | 995.6% |
| 2015 Q3 | 4956.00 KRW | 102.62% |
| 2015 Q2 | 2446.00 KRW | 127.75% |
| 2014 Q4 | -119.92 KRW | -103.09% |
| 2014 Q3 | 3886.00 KRW | 266.6% |
| 2014 Q1 | 2434.00 KRW | 1727.33% |
| 2014 Q2 | 1060.00 KRW | -56.45% |
| 2014 FY | - KRW | 18.24% |
| 2013 Q3 | 2829.00 KRW | 98.95% |
| 2013 Q1 | 1652.74 KRW | 390.92% |
| 2013 Q4 | 133.20 KRW | -95.29% |
| 2013 FY | - KRW | 24.09% |
| 2013 Q2 | 1422.00 KRW | -13.96% |
| 2012 Q1 | 1458.74 KRW | 1639.24% |
| 2012 Q4 | -568.11 KRW | -120.23% |
| 2012 Q3 | 2808.35 KRW | 187.03% |
| 2012 Q2 | 978.40 KRW | -32.93% |
| 2012 FY | - KRW | -4.31% |
| 2011 Q4 | -94.77 KRW | -103.04% |
| 2011 FY | - KRW | -51.13% |
| 2011 Q3 | 3116.14 KRW | 216.38% |
| 2011 Q2 | 984.93 KRW | -18.71% |
| 2011 Q1 | 1211.57 KRW | 263.77% |
| 2010 Q1 | 6647.62 KRW | 50.59% |
| 2010 Q3 | 3006.45 KRW | 80.53% |
| 2010 Q4 | -739.82 KRW | -124.61% |
| 2010 FY | - KRW | 27.68% |
| 2010 Q2 | 1665.35 KRW | -74.95% |
| 2009 Q2 | 1491.74 KRW | 86.88% |
| 2009 Q1 | 798.23 KRW | -22.19% |
| 2009 Q3 | 1569.82 KRW | 5.23% |
| 2009 Q4 | 4414.36 KRW | 181.2% |
| 2009 FY | - KRW | 63.28% |
| 2008 Q4 | 1025.81 KRW | 0.16% |
| 2008 FY | - KRW | 9.6% |
| 2008 Q3 | 1024.20 KRW | -47.36% |
| 2008 Q2 | 1945.51 KRW | 80.1% |
| 2008 Q1 | 1080.23 KRW | 189.16% |
| 2007 Q1 | 1057.62 KRW | 0.0% |
| 2007 Q3 | 1767.35 KRW | 23.49% |
| 2007 Q4 | 373.57 KRW | -78.86% |
| 2007 FY | - KRW | 0.0% |
| 2007 Q2 | 1431.12 KRW | 35.32% |
| Name | Eps | Eps Difference |
|---|---|---|
| ORIENT BIO Inc. | 108.55 KRW | 2249.627% |
| Green Cross Holdings Corporation | -1210.00 KRW | -92.845% |
| Pharmicell Co., Ltd. | 60.00 KRW | 3989.033% |
| Green Cross Corporation | -2333.42 KRW | -0.0% |
| GeneOne Life Science, Inc. | -1000.23 KRW | -133.288% |
| Celltrion, Inc. | 3759.00 KRW | 162.076% |
| Samsung Biologics Co.,Ltd. | 12.05 Thousand KRW | 119.364% |
| SK bioscience Co.,Ltd. | 291.00 KRW | 901.863% |
| SK Biopharmaceuticals Co., Ltd. | -419.89 KRW | -455.722% |
| Prestige BioPharma Limited | -547.81 KRW | -325.954% |